Carbapenem-resistant Enterobacteriaceae in the community: a scoping review
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Carbapenem antibiotics are used as a last resort to treat serious Gram-negative bacteria (GNB) infections, however carbapenemase-producing strains of GNB have emerged as a major source of resistance. Owing to the highly transmissible nature of plasmid-borne carbapenemases, numerous reports have warned about the likely spread into the community from healthcare settings. Since the prevalence of carbapenem-resistant Enterobacteriaceae (CRE) in the community is largely unknown, we conducted a scoping review of the literature to assess the percentage of CRE isolates that could be associated with the community. Initially, 361 studies were assessed and 15 met the inclusion criteria. Although 5 studies (33.3%) found no community-associated CRE, the remaining 10 studies identified percentages ranging from 0.04% to 29.5% of either community-associated or community-onset CRE among their samples, with US-based studies alone ranging from 5.6–10.8%. The presence of CRE in the community poses an urgent public health threat.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Liu, Y.-Y., Wang, Y., Walsh, T. R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00424-7 · Cited by 5,398 · cited 1×
“Researchers in China discovered colistin resistance encoded on a plasmid among livestock [54].”
BackgroundA scoping review of scoping reviews: advancing the approach and enhancing the consistency
Pham, M. T., Rajić, A., Greig, J. D., Sargeant, J. M., Papadopoulos, A., & McEwen, S. A. (2014) · Research Synthesis Methods · doi:10.1002/jrsm.1123 · Cited by 3,078 · cited 1×
“Scoping reviews are often selected over systematic reviews when the topic of interest is heterogeneous in nature and has not been well reviewed [32].”
BackgroundKumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922 · cited 2×
“, for example, tested for the presence of CRE conferred by NDM among Enterobacteriaceae and found that the majority of samples in India arose from the community [30].”
BackgroundFriedman, N. D., Kaye, K. S., Stout, J. E., McGarry, S. A., Trivette, S. L., Briggs, J. P., Lamm, W., Clark, C., MacFarquhar, J., Walton, A. L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-10-200211190-00007 · Cited by 1,668 · cited 1×
“The CDC defines CAI as any infection that is not associated with the hospital [47], but there is an important distinction between CAIs and community-onset infections.”
BackgroundYigit, H., Queenan, A. M., Anderson, G. J., Domenech-Sanchez, A., Biddle, J. W., Steward, C. D., Alberti, S., Bush, K., & Tenover, F. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1151-1161.2001 · Cited by 1,639 · cited 1×
“Since the first published case of CRE was in 1996 [34], we conducted a literature search through PubMed and Embase electronic databases for articles published from 1996 through March 2016.”
MethodClinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
Munoz-Price, L. S., Poirel, L., Bonomo, R. A., Schwaber, M. J., Daikos, G. L., Cormican, M., Cornaglia, G., Garau, J., Gniadkowski, M., Hayden, M. K., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70190-7 · Cited by 1,627 · cited 3×
“Although only four studies in this review included a genomic analysis of carbapenemases, their findings support previous findings of geographic distribution, namely KPC most common in a US sample, NDM in an Asian sample and VIM in southern European samples [10,11,14].”
BackgroundResultWalsh, T. R., Weeks, J., Livermore, D. M., & Toleman, M. A. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70059-7 · Cited by 1,250 · cited 1×
“A study in India demonstrated the importance of environmental sampling after discovering carbapenemases in drinking water [53].”
BackgroundCarbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention
Gupta, N., Limbago, B. M., Patel, J. B., & Kallen, A. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir202 · Cited by 1,033 · cited 2×
“The molecular epidemiology of CRE from healthcare settings has been well described in the USA and elsewhere [5,10,14].”
BackgroundRapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
Cantón, R., Akóva, M., Carmeli, Y., Giske, C. G., Glupczynski, Y., Gniadkowski, M., Livermore, D. M., Miriagou, V., Naas, T., Rossolini, G. M., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03821.x · Cited by 883 · cited 1×
“Although only four studies in this review included a genomic analysis of carbapenemases, their findings support previous findings of geographic distribution, namely KPC most common in a US sample, NDM in an Asian sample and VIM in southern European samples [10,11,14].”
ResultThe difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide
Nordmann, P., & Poirel, L. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12719 · Cited by 679 · cited 2×
“Although only four studies in this review included a genomic analysis of carbapenemases, their findings support previous findings of geographic distribution, namely KPC most common in a US sample, NDM in an Asian sample and VIM in southern European samples [10,11,14].”
BackgroundResultCarbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding
Chen, L., Mathema, B., Chavda, K. D., DeLeo, F. R., Bonomo, R. A., & Kreiswirth, B. N. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.09.003 · Cited by 554 · cited 8×
“• Percentage of community-based CRE was highest in parts of Asia.”
MethodInfluentialSelf-citationSchwaber, M. J., Lev, B., Israeli, A., Solter, E., Smollan, G., Rubinovitch, B., Shalit, I., Carmeli, Y., & the Israel Carbapenem-Resistant Enterobacteriaceae Working Group (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir025 · Cited by 453 · cited 10×
“Of these four, the US-based study identified KPC as the most common carbapenemase [25], the study conducted primarily in India found the greatest frequency of NDM [44], VIM was most common in the study conducted in Spain [46] and a single case of IMP was identified in an Australian cohort [43].”
BackgroundInfluentialPotent CD8+ T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA-NP+M1
Berthoud, T. K., Hamill, M., Lillie, P. J., Hwenda, L., Collins, K. A., Ewer, K. J., Milicic, A., Poyntz, H. C., Lambe, T., Fletcher, H. A., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq015 · Cited by 384
Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013
Guh, A. Y., Bulens, S. N., Mu, Y., Jacob, J. T., Reno, J., Scott, J., Wilson, L. E., Vaeth, E., Lynfield, R., Shaw, K. M., et al. (2015) · JAMA · doi:10.1001/jama.2015.12480 · Cited by 369 · cited 8×
“Of these four, the US-based study identified KPC as the most common carbapenemase [25], the study conducted primarily in India found the greatest frequency of NDM [44], VIM was most common in the study conducted in Spain [46] and a single case of IMP was identified in an Australian cohort [43].”
BackgroundResultInfluentialTischendorf, J. S., de Avila, R. A., & Safdar, N. (2016) · American Journal of Infection Control · doi:10.1016/j.ajic.2015.12.005 · Cited by 356 · cited 2×
“Colonisation with CRE is most often defined by gastrointestinal tract carriage identified through the use of a rectal swab or faecal sampling [31].”
BackgroundCarbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes
van Duin, D., Kaye, K. S., Neuner, E. A., & Bonomo, R. A. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.11.009 · Cited by 352 · cited 2×
“Both for CAIs and HAIs, the majority of CRE are isolated from urine, with higher rates of faecal carriage as well [4].”
BackgroundMcGann, P., Snesrud, E., Maybank, R., Corey, B., Ong, A. C., Clifford, R., Hinkle, M., Whitman, T., Lesho, E., & Schaecher, K. E. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01103-16 · Cited by 350
Proliferation and significance of clinically relevant β‐lactamases
Bush, K. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12023 · Cited by 337 · cited 9×
“Of these four, the US-based study identified KPC as the most common carbapenemase [25], the study conducted primarily in India found the greatest frequency of NDM [44], VIM was most common in the study conducted in Spain [46] and a single case of IMP was identified in an Australian cohort [43].”
BackgroundInfluentialTängdén, T., & Giske, C. G. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12342 · Cited by 322 · cited 1×
“Hence, risk factors for colonisation and/or infection are the same as other drugresistant organisms [12,13,35].”
BackgroundCarbapenem‐resistant Enterobacteriaceae: biology, epidemiology, and management
Temkin, E., Adler, A., Lerner, A., & Carmeli, Y. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12537 · Cited by 223 · cited 1×
“Initially, CRE had been primarily reported from high-income countries [26,27], but regional patterns of resistance vary, with the highest proportion of carbapenem resistance found in India at 57% among K.”
BackgroundWhat Is Community‐Associated Methicillin‐Resistant Staphylococcus aureus?
David, M. Z., Glikman, D., Crawford, S. E., Peng, J., King, K. J., Hostetler, M. A., Boyle‐Vavra, S., & Daum, R. S. (2008) · The Journal of Infectious Diseases · doi:10.1086/533502 · Cited by 203
Sheng, W.-H., Badal, R. E., & Hsueh, P.-R. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00971-12 · Cited by 185
Hayden, M. K., Lin, M. Y., Lolans, K., Weiner, S., Blom, D., Moore, N. M., Fogg, L., Henry, D., Lyles, R., Thurlow, C., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu1173 · Cited by 184 · cited 1×
“Transmission of CRE into long-term care facilities (LTCFs) has already been demonstrated [10,15,16], but there is a lack of data and consensus on the presence of CRE among individuals in the community with no known connection to the healthcare setting.”
BackgroundAlexopoulou, A. A., Papadopoulos, N., Eliopoulos, D. G., Alexaki, A., Tsiriga, A., Toutouza, M. G., & Pectasides, D. G. (2013) · Liver International · doi:10.1111/liv.12152 · Cited by 140 · cited 9×
“Further, we present the proportion of CAI/CO-CRE in order to provide a comparable percentage among the various studies, but study design and sample size variation may have impacted the precision of the true proportion.”
BackgroundInfluentialNDM‐1, the ultimate promiscuous enzyme: substrate recognition and catalytic mechanism
Kim, Y., Cunningham, M. A., Mire, J., Tesar, C., Sacchettini, J. C., & Joachimiak, A. (2013) · The FASEB Journal · doi:10.1096/fj.12-224014 · Cited by 126 · cited 1×
“Although KPC is the most common carbapenemase worldwide, NDMs have been shown to be more promiscuous [19].”
BackgroundThaden, J. T., Lewis, S. S., Hazen, K. C., Huslage, K., Fowler, V. G., Moehring, R. W., Chen, L. F., Jones, C. D., Moore, Z., Sexton, D. J., et al. (2014) · Infection Control and Hospital Epidemiology · doi:10.1086/677157 · Cited by 123 · cited 12×
“The CDC defines CAI as any infection that is not associated with the hospital [47], but there is an important distinction between CAIs and community-onset infections.”
BackgroundInfluentialPrabaker, K. K., Lin, M. Y., McNally, M., Cherabuddi, K., Ahmed, S. S., Norris, A., Lolans, K., Odeh, R. M., Chundi, V. V., Weinstein, R. A., et al. (2012) · Infection Control and Hospital Epidemiology · doi:10.1086/668435 · Cited by 110 · cited 1×
“Long-term care settings, for example, are important reservoirs for community-onset, healthcare-associated transmission [37,50,51].”
BackgroundLerner, A. O., Adler, A., Abu-Hanna, J., Percia, S. C., Kazma, M., & Carmeli, Y. (2014) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.12.015 · Cited by 102 · cited 1×
“Initially, CRE had been primarily reported from high-income countries [26,27], but regional patterns of resistance vary, with the highest proportion of carbapenem resistance found in India at 57% among K.”
BackgroundPecora, N., Li, N., Allard, M. W., Li, C., Albano, E., Delaney, M. L., DuBois, A. M., Onderdonk, A. B., & Bry, L. (2015) · mBio · doi:10.1128/mbio.01030-15 · Cited by 99
Resistant Gram-negative infections in the outpatient setting in Latin America
Salles, M. J. C., Zurita, J., Mejía, C., & Villegas, M. V. (2013) · Epidemiology and Infection · doi:10.1017/s095026881300191x · Cited by 91 · cited 1×
“This follows the same pattern demonstrated by ESBL, in which communityassociated UTIs began to develop increased resistance [9] and resistant strains were found in healthy faecal samples [8].”
BackgroundGijón-Cordero, D., Curião, T., Baquero, F., Coque, T. M., & Cantón, R. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00020-12 · Cited by 81 · cited 4×
“Five studies tested specifically for colonisation, with three finding faecal carriage of CRE [29,45,46] ranging from 1.”
BackgroundResultInfluentialRossi, I., Ferreira, M. L., Araújo, B. F., de Campos, P. A., Royer, S., Batistão, D. W. D. F., de Souza, L. P. M., de Brito, C. S., Urzêdo, J. E., Gontijo-Filho, P. P., et al. (2016) · Journal of Hospital Infection · doi:10.1016/j.jhin.2016.08.019 · Cited by 69 · cited 1×
“Colistin is one of the few treatment options available for CRE, yet increasing accounts of colistin resistance are also being documented [21,22].”
BackgroundErgönül, Ö., Aydın, M., Azap, A., Başaran, S., Tekin, S., Kaya, Ş., Gülsün, S., Yörük, G., Kurşun, E., Yesilkaya, A., et al. (2016) · Journal of Hospital Infection · doi:10.1016/j.jhin.2016.08.012 · Cited by 69 · cited 1×
“Colistin is one of the few treatment options available for CRE, yet increasing accounts of colistin resistance are also being documented [21,22].”
BackgroundTang, H.-J., Hsieh, C., Chang, P., Chen, J.-J., Lin, Y., Lai, C., Chao, C., & Chuang, Y.-C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151897 · Cited by 58 · cited 5×
“pneumoniae was the most common organism [16,25,36,37], except a US-based study that had a slightly higher percentage of Enterobacter spp.”
BackgroundInfluentialStatewide Surveillance of Carbapenem-Resistant Enterobacteriaceae in Michigan
Brennan, B. M., Coyle, J. R., Marchaim, D., Pogue, J. M., Boehme, M. S., Finks, J. L., Malani, A. N., VerLee, K. E., Buckley, B. O., Mollon, N., et al. (2014) · Infection Control and Hospital Epidemiology · doi:10.1086/675611 · Cited by 56 · cited 5×
“One study reported a prevalence of 29% CRE colonisation or previous CRE infection prior to admission as a risk factor for subsequent CRE infection [37].”
BackgroundInfluentialSavard, P., & Perl, T. M. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12748 · Cited by 54 · cited 2×
“Hence, risk factors for colonisation and/or infection are the same as other drugresistant organisms [12,13,35].”
BackgroundVillar, H. E., Baserni, M. N., & Jugo, M. B. (2013) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.2900 · Cited by 44 · cited 3×
“Five studies tested specifically for colonisation, with three finding faecal carriage of CRE [29,45,46] ranging from 1.”
BackgroundMiller, B. M., & Johnson, S. W. (2015) · American Journal of Infection Control · doi:10.1016/j.ajic.2015.09.006 · Cited by 43 · cited 4×
“Hence, risk factors for colonisation and/or infection are the same as other drugresistant organisms [12,13,35].”
BackgroundInfluentialCoccolini, F., Sartelli, M., Catena, F., Montori, G., Saverio, S. D., Sugrue, M., Ceresoli, M., Manfredi, R., & Ansaloni, L. (2015) · International Journal of Surgery · doi:10.1016/j.ijsu.2015.07.013 · Cited by 40 · cited 10×
“A variety of automated systems were used to identify CRE among the isolates, with all but one study [38] documenting the use of the Clinical and Laboratory Standards Institute (CLSI) breakpoints for the minimum inhibitory concentration (MIC) for carbapenem susceptibility testing.”
BackgroundMethodInfluentialVlieghe, E., Huang, T.-D., Phe, T., Bogaerts, P., Berhin, C., Smet, B. D., Peetermans, W. E., Jacobs, J. A., & Glupczynski, Y. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2350-9 · Cited by 33 · cited 4×
“These included cancer [36], diabetes [25,35], human immunodeficiency virus (HIV) [42] and cardiovascular disease [37,38].”
BackgroundInfluentialGarrido, A., Seral, C., Gude, M. J., Casado, C., González‐Domínguez, M., Sáenz, Y., & Castillo, F. J. (2013) · Microbial Drug Resistance · doi:10.1089/mdr.2013.0109 · Cited by 19 · cited 4×
“0%) provided no formal definition for CAI versus HAI, four of these considered their entire sample ‘community’ because all isolates were obtained from outpatients [40,41,43,45].”
BackgroundInfluentialEbrahimi, F., Mózes, J., Mészáros, J., Juhász, Á., & Kardos, G. (2014) · Chemotherapy · doi:10.1159/000375407 · Cited by 18
Lohiya, A. (2015) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2015/14230.6254 · Cited by 11 · cited 4×
“0%) provided no formal definition for CAI versus HAI, four of these considered their entire sample ‘community’ because all isolates were obtained from outpatients [40,41,43,45].”
BackgroundInfluential
Cited by
Carbapenem Resistance: A Review
Codjoe, F., & Donkor, E. (2017) · Medical Sciences · doi:10.3390/medsci6010001 · Cited by 746
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria
Jean, S.-S., Harnod, D., & Hsueh, P.-R. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.823684 · Cited by 366
Genomics and pathotypes of the many faces of Escherichia coli
Geurtsen, J., de Been, M., Weerdenburg, E., Zomer, A., McNally, A., & Poolman, J. (2022) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuac031 · Cited by 235
“2018), and that 5%– 10% of these carbapenem-resistant Enterobacteriaceae (CRE) have been found to be community-associated in the US (Kelly et al. 2017).”
BackgroundD’Accolti, M., Soffritti, I., Bini, F., Mazziga, E., Mazzacane, S., & Caselli, E. (2022) · Microorganisms · doi:10.3390/microorganisms10020225 · Cited by 39
“have been also often reported in community non-healthcare environments, highlighting the potential threat for public health [77,78].”
Background
Metadata
- Authors
- Kelly, A. M., Mathema, B., & Larson, E. L.
- Venue
- International Journal of Antimicrobial Agents
- Publisher
- Elsevier BV
- Published
- 2017-08
- Volume
- 50
- Issue
- 2
- Pages
- 127-134
- ISSN
- 0924-8579 (ISSN-L)
- OpenAlex
- W2706794697
- Cited by
- 242
- References
- 46
- FWCI
- 7.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.